1-2 of 2
janus kinase
Close
Sort by
Journal Articles

Evidence for Janus kinase (JAK) inhibitors for the prevention of major morbid events in patients with myeloproliferative neoplasms (MPNs)

Naveen Pemmaraju, Ruben Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 649–651.
https://doi.org/10.1182/asheducation-2015.1.649
Published: 2015
Journal Articles

The Genetic Basis of Myeloproliferative Disorders

Radek Skoda
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 1–10.
https://doi.org/10.1182/asheducation-2007.1.1
Published: 2007